Bussone To Head Operating Unit At MedCath
August 18, 2009 (FinancialWire) — MedCath Corp. (NASDAQ: MDTH) (Current Market Cap: $184.43 Mil.) has named David Bussone executive vice president and president of the company’s operating division.
Bussone joins MedCath after serving as senior vice president for Universal Health Services, Inc.’s (NYSE: UHS) acute division. He spent four years at UHS. Prior to that, Bussone spent three years as CEO of two Hospital Corp. of America hospitals in Florida. This was his second stint with HCA after beginning his career there in 1979 as an associate administrator.
IN his new role at MedCatch, Bussone will oversee the company’s hospital division, MedCath Partners and Service Centers in Charlotte and Dallas that support operations, such as physician recruiting, management engineering, supply chain management and marketing.
Charlotte, North Carolina-based MedCath is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering.
The company owns an interest in and operates nine hospitals with a total of 755 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
